{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:35:26Z","timestamp":1781307326465,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12149-025-02078-9","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:44:12Z","timestamp":1751539452000},"page":"1192-1200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u0394BSIJ: a quantitative marker for early detection of medication-related osteonecrosis of the jaw in patients with prostate cancer receiving bone-modifying agents"],"prefix":"10.1007","volume":"39","author":[{"given":"Hidetoshi","family":"Kokubun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-9294","authenticated-orcid":false,"given":"Toshiki","family":"Kijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuumi","family":"Tokura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Uematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Betsunoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyoshi","family":"Soga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"2078_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bjoms.2020.03.010","volume":"58","author":"J Murphy","year":"2020","unstructured":"Murphy J, Mannion CJ. Medication-related osteonecrosis of the jaws and quality of life: review and structured analysis. Br J Oral Maxillofac Surg. 2020;58:619\u201324.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"2078_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/odi.13737","volume":"28","author":"LY Wei","year":"2022","unstructured":"Wei LY, et al. Prognosis of medication-related osteonecrosis of the jaws in metastatic prostate cancer patients. Oral Dis. 2022;28:182\u201392.","journal-title":"Oral Dis"},{"key":"2078_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jcms.2014.11.014","volume":"43","author":"O Ristow","year":"2015","unstructured":"Ristow O, et al. Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ). J Craniomaxillofac Surg. 2015;43:290\u20133.","journal-title":"J Craniomaxillofac Surg"},{"key":"2078_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00784-009-0293-1","volume":"14","author":"P Stockmann","year":"2010","unstructured":"Stockmann P, et al. Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Investig. 2010;14:311\u20137.","journal-title":"Clin Oral Investig"},{"key":"2078_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12149-019-01417-x","volume":"34","author":"Y Yamamoto","year":"2020","unstructured":"Yamamoto Y, et al. Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early. Ann Nucl Med. 2020;34:74\u20139.","journal-title":"Ann Nucl Med"},{"key":"2078_CR6","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.joms.2009.03.005","volume":"67","author":"FS O\u2019Ryan","year":"2009","unstructured":"O\u2019Ryan FS, et al. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. J Oral Maxillofac Surg. 2009;67:1363\u201372.","journal-title":"J Oral Maxillofac Surg"},{"key":"2078_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00784-015-1563-8","volume":"20","author":"C Thomas","year":"2016","unstructured":"Thomas C, et al. Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC). Clin Oral Investig. 2016;20:753\u20138.","journal-title":"Clin Oral Investig"},{"key":"2078_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12149-016-1145-0","volume":"31","author":"S Watanabe","year":"2017","unstructured":"Watanabe S, et al. Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis. Ann Nucl Med. 2017;31:201\u201310.","journal-title":"Ann Nucl Med"},{"key":"2078_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eururo.2012.01.037","volume":"62","author":"D Ulmert","year":"2012","unstructured":"Ulmert D, et al. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the bone scan index. Eur Urol. 2012;62:78\u201384.","journal-title":"Eur Urol"},{"key":"2078_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/2191-219X-3-83","volume":"3","author":"K Nakajima","year":"2013","unstructured":"Nakajima K, et al. Enhanced diagnostic accuracy for quantitative bone scan using an artificial neural network system: a Japanese multi-center database project. EJNMMI Res. 2013;3:83.","journal-title":"EJNMMI Res"},{"key":"2078_CR11","doi-asserted-by":"publisher","first-page":"20200417","DOI":"10.1259\/dmfr.20200417","volume":"50","author":"P Wongratwanich","year":"2021","unstructured":"Wongratwanich P, et al. Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review. Dento Maxillo Fac Radiol. 2021;50:20200417.","journal-title":"Dento Maxillo Fac Radiol"},{"key":"2078_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/pcan.2016.71","volume":"20","author":"AH Bryce","year":"2017","unstructured":"Bryce AH, et al. Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL. Prostate Cancer Prostatic Dis. 2017;20:221\u20137.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2078_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.euo.2020.07.001","volume":"3","author":"AH Bryce","year":"2020","unstructured":"Bryce AH, et al. Patterns of cancer progression of metastatic hormone-sensitive prostate cancer in the ECOG3805 CHAARTED trial. Eur Urol Oncol. 2020;3:717\u201324.","journal-title":"Eur Urol Oncol"},{"key":"2078_CR14","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/pros.24588","volume":"83","author":"T Hara","year":"2023","unstructured":"Hara T, et al. Real-world analysis of metastatic prostate cancer demonstrates increased frequency of PSA-imaging discordance with visceral metastases and upfront ARAT\/docetaxel therapy. Prostate. 2023;83:1270\u20138.","journal-title":"Prostate"},{"key":"2078_CR15","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.3390\/jcm12113747","volume":"12","author":"GA Ciobanu","year":"2023","unstructured":"Ciobanu GA, et al. Risk factors for medication-related osteonecrosis of the jaw-a binomial analysis of data of cancer patients from craiova and constanta treated with zoledronic acid. J Clin Med. 2023;12:3747.","journal-title":"J Clin Med"},{"key":"2078_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5125\/jkaoms.2023.49.3.135","volume":"49","author":"DW Kwack","year":"2023","unstructured":"Kwack DW, Park SM. Prediction of medication-related osteonecrosis of the jaw (MRONJ) using automated machine learning in patients with osteoporosis associated with dental extraction and implantation: a retrospective study. J Korean Assoc Oral Maxillofac Surg. 2023;49:135\u201341.","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"2078_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40902-023-00398-2","volume":"45","author":"YD Kwon","year":"2023","unstructured":"Kwon YD, et al. A clinical retrospective study of implant as a risk factor for medication-related osteonecrosis of the jaw: surgery vs loading? Maxillofac Plast Reconstr Surg. 2023;45:31.","journal-title":"Maxillofac Plast Reconstr Surg"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02078-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:30:47Z","timestamp":1761571847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02078-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2078"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02078-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5795022\/v1","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflicts of interest were disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study registration"}}]}}